JP2018516984A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516984A5 JP2018516984A5 JP2018513745A JP2018513745A JP2018516984A5 JP 2018516984 A5 JP2018516984 A5 JP 2018516984A5 JP 2018513745 A JP2018513745 A JP 2018513745A JP 2018513745 A JP2018513745 A JP 2018513745A JP 2018516984 A5 JP2018516984 A5 JP 2018516984A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- hpv
- composition according
- item
- rnp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562168188P | 2015-05-29 | 2015-05-29 | |
| US62/168,188 | 2015-05-29 | ||
| PCT/US2016/034627 WO2016196282A1 (en) | 2015-05-29 | 2016-05-27 | Compositions and methods for cell targeted hpv treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018516984A JP2018516984A (ja) | 2018-06-28 |
| JP2018516984A5 true JP2018516984A5 (enExample) | 2019-06-27 |
Family
ID=56137529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513745A Pending JP2018516984A (ja) | 2015-05-29 | 2016-05-27 | 細胞を標的にしたｈｐｖ処置のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20160346360A1 (enExample) |
| EP (1) | EP3324999A1 (enExample) |
| JP (1) | JP2018516984A (enExample) |
| CA (1) | CA3000155A1 (enExample) |
| GB (1) | GB2543873A (enExample) |
| WO (1) | WO2016196282A1 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2734621B1 (en) | 2011-07-22 | 2019-09-04 | President and Fellows of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| AU2014207618A1 (en) | 2013-01-16 | 2015-08-06 | Emory University | Cas9-nucleic acid complexes and uses related thereto |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US9340800B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | Extended DNA-sensing GRNAS |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| CA2956224A1 (en) | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| US10117911B2 (en) | 2015-05-29 | 2018-11-06 | Agenovir Corporation | Compositions and methods to treat herpes simplex virus infections |
| US20160346360A1 (en) * | 2015-05-29 | 2016-12-01 | Agenovir Corporation | Compositions and methods for cell targeted hpv treatment |
| CA2999922A1 (en) * | 2015-09-29 | 2017-04-06 | Agenovir Corporation | Delivery methods and compositions |
| EP4434589A3 (en) | 2015-10-23 | 2025-05-14 | President and Fellows of Harvard College | Evolved cas9 proteins for gene editing |
| JP7231935B2 (ja) | 2016-08-03 | 2023-03-08 | プレジデント アンド フェローズ オブ ハーバード カレッジ | アデノシン核酸塩基編集因子およびそれらの使用 |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| AU2017342543B2 (en) | 2016-10-14 | 2024-06-27 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
| WO2018118585A1 (en) * | 2016-12-22 | 2018-06-28 | Agenovir Corporation | Antiviral compositions |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| US20180201921A1 (en) * | 2017-01-18 | 2018-07-19 | Excision Biotherapeutics, Inc. | CRISPRs |
| US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| CN110662556A (zh) | 2017-03-09 | 2020-01-07 | 哈佛大学的校长及成员们 | 癌症疫苗 |
| JP2020510439A (ja) | 2017-03-10 | 2020-04-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | シトシンからグアニンへの塩基編集因子 |
| WO2018175502A2 (en) * | 2017-03-21 | 2018-09-27 | Shuber Anthony P | Treating cancer with cas endonuclease complexes |
| WO2018176009A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| CN110678548A (zh) * | 2017-03-31 | 2020-01-10 | 埃吉诺维亚公司 | 抗病毒治疗剂 |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
| WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
| KR20200121782A (ko) | 2017-10-16 | 2020-10-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | 아데노신 염기 편집제의 용도 |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| WO2020154500A1 (en) | 2019-01-23 | 2020-07-30 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| MX2021011426A (es) | 2019-03-19 | 2022-03-11 | Broad Inst Inc | Metodos y composiciones para editar secuencias de nucleótidos. |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| US20230044432A1 (en) * | 2019-12-03 | 2023-02-09 | Université de Liège | Pooled Crispr Inverse PCR Sequencing (PCIP-Seq): Simultaneous Sequencing of Viral Insertion Points and the Integrated Viral Genomes with Long Reads |
| CN111018956B (zh) * | 2019-12-30 | 2020-10-09 | 鼓润(武汉)医疗科技有限公司 | 一种靶向敲除hpv urr基因的dna结合蛋白、系统及其应用 |
| WO2021226558A1 (en) | 2020-05-08 | 2021-11-11 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| CN113952475B (zh) * | 2021-09-27 | 2025-03-11 | 中国人民解放军陆军军医大学 | 淋巴细胞和介导crispr系统的纳米复合物联合在制备治疗宫颈癌药物中的应用 |
| CN116004716A (zh) * | 2022-09-09 | 2023-04-25 | 华中农业大学 | 一种复制型dCas9-FokI系统进行高效基因编辑的方法 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5580571A (en) | 1991-10-15 | 1996-12-03 | Hostetler; Karl Y. | Nucleoside analogues |
| SE9200951D0 (sv) | 1992-03-27 | 1992-03-27 | Kabi Pharmacia Ab | Pharmaceutical composition containing a defined lipid system |
| US5436150A (en) | 1992-04-03 | 1995-07-25 | The Johns Hopkins University | Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease |
| US5356802A (en) | 1992-04-03 | 1994-10-18 | The Johns Hopkins University | Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease |
| US5487994A (en) | 1992-04-03 | 1996-01-30 | The Johns Hopkins University | Insertion and deletion mutants of FokI restriction endonuclease |
| JPH09500013A (ja) | 1993-06-01 | 1997-01-07 | ライフ・テクノロジーズ・インコーポレイテッド | カチオン性脂質による遺伝子免疫 |
| US6140466A (en) | 1994-01-18 | 2000-10-31 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
| US6242568B1 (en) | 1994-01-18 | 2001-06-05 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
| DE69535829D1 (de) | 1994-08-20 | 2008-10-16 | Gendaq Ltd | Verbesserung in bezug auf bindungsproteine bei der erkennung von dna |
| US5789538A (en) | 1995-02-03 | 1998-08-04 | Massachusetts Institute Of Technology | Zinc finger proteins with high affinity new DNA binding specificities |
| US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
| US6410248B1 (en) | 1998-01-30 | 2002-06-25 | Massachusetts Institute Of Technology | General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US8409861B2 (en) | 2003-08-08 | 2013-04-02 | Sangamo Biosciences, Inc. | Targeted deletion of cellular DNA sequences |
| GB0526211D0 (en) | 2005-12-22 | 2006-02-01 | Oxford Biomedica Ltd | Viral vectors |
| DE602007005634D1 (de) | 2006-05-25 | 2010-05-12 | Sangamo Biosciences Inc | Variante foki-spaltungshälften-domänen |
| US20110023144A1 (en) | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved in amyotrophyic lateral sclerosis disease |
| US9637739B2 (en) | 2012-03-20 | 2017-05-02 | Vilnius University | RNA-directed DNA cleavage by the Cas9-crRNA complex |
| WO2014093622A2 (en) * | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| EP4282970A3 (en) | 2012-12-17 | 2024-01-17 | President and Fellows of Harvard College | Rna-guided human genome engineering |
| IL289396B2 (en) | 2013-03-15 | 2023-12-01 | The General Hospital Coporation | Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing |
| US9234213B2 (en) | 2013-03-15 | 2016-01-12 | System Biosciences, Llc | Compositions and methods directed to CRISPR/Cas genomic engineering systems |
| US20140349400A1 (en) | 2013-03-15 | 2014-11-27 | Massachusetts Institute Of Technology | Programmable Modification of DNA |
| WO2014165349A1 (en) * | 2013-04-04 | 2014-10-09 | Trustees Of Dartmouth College | Compositions and methods for in vivo excision of hiv-1 proviral dna |
| CA2915837A1 (en) * | 2013-06-17 | 2014-12-24 | The Broad Institute, Inc. | Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation |
| EP3038661B1 (en) * | 2013-08-29 | 2023-12-27 | Temple University Of The Commonwealth System Of Higher Education | Methods and compositions for rna-guided treatment of hiv infection |
| US9526784B2 (en) * | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| JP2016536021A (ja) * | 2013-11-07 | 2016-11-24 | エディタス・メディシン，インコーポレイテッド | ＣＲＩＳＰＲ関連方法および支配ｇＲＮＡのある組成物 |
| KR20160130392A (ko) * | 2014-02-18 | 2016-11-11 | 듀크 유니버시티 | 바이러스 복제의 불활성화를 위한 조성물 및 그의 제조 및 사용 방법 |
| US10507232B2 (en) * | 2014-04-02 | 2019-12-17 | University Of Florida Research Foundation, Incorporated | Materials and methods for the treatment of latent viral infection |
| BR112016028023A2 (pt) * | 2014-05-30 | 2017-08-22 | Univ Leland Stanford Junior | Composições e métodos de administração de tratamentos para infecções virais latentes |
| US20160346360A1 (en) * | 2015-05-29 | 2016-12-01 | Agenovir Corporation | Compositions and methods for cell targeted hpv treatment |
| EP3331571A4 (en) * | 2015-05-29 | 2019-04-10 | Agenovir Corporation | COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS |
| JP2018516596A (ja) * | 2015-05-29 | 2018-06-28 | アジェノビア コーポレーション | 抗ウイルスの方法および組成物 |
-
2016
- 2016-05-27 US US15/166,936 patent/US20160346360A1/en not_active Abandoned
- 2016-05-27 JP JP2018513745A patent/JP2018516984A/ja active Pending
- 2016-05-27 EP EP16730570.5A patent/EP3324999A1/en not_active Withdrawn
- 2016-05-27 WO PCT/US2016/034627 patent/WO2016196282A1/en not_active Ceased
- 2016-05-27 GB GB1609438.5A patent/GB2543873A/en not_active Withdrawn
- 2016-05-27 CA CA3000155A patent/CA3000155A1/en not_active Abandoned
-
2018
- 2018-12-18 US US16/224,591 patent/US20190201501A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018516984A5 (enExample) | ||
| JP2018516983A5 (enExample) | ||
| Xu et al. | Delivery of CRISPR/Cas9 for therapeutic genome editing | |
| EP3417062B1 (en) | Excision of retroviral nucleic acid sequences | |
| US9981020B2 (en) | Methods and compositions for RNA-guided treatment of HIV infection | |
| JP2017518075A5 (enExample) | ||
| US20190010518A1 (en) | Compositions and Methods of Delivering Treatments for Latent Viral Infections | |
| US20190093092A1 (en) | Rna guided eradication of varicella zoster virus | |
| RU2747722C2 (ru) | Направляемое РНК уничтожение вируса JC человека и других полиомавирусов | |
| CN108883201A (zh) | Rna指导的治疗hiv感染的方法和组合物 | |
| JP2019512458A (ja) | Ｒｎａによって誘導された、ヒトｊｃウイルス及び他のポリオーマウイルスの根絶 | |
| WO2016150336A1 (zh) | 一种CRISPR-Cas9系统及其制备方法和应用 | |
| JP2017518372A5 (enExample) | ||
| WO2018112470A1 (en) | Co-delivery of nucleic acids for simultaneous suppression and expression of target genes | |
| Avila et al. | Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules | |
| Abbaszadeh-Goudarzi et al. | Targeted delivery of CRISPR/Cas13 as a promising therapeutic approach to treat SARS-CoV-2 | |
| CN118973610A (zh) | 通过中断细胞和病毒受体相互作用来阻断asfv感染的方法 | |
| JP2008531672A5 (enExample) | ||
| Liu et al. | Towards the elimination of infectious HPV: exploiting CRISPR/Cas innovations | |
| Zuo et al. | Nuclear‐Targeting Delivery of CRISPRa System for Upregulation of β‐Defensin against Virus Infection by Dexamethasone and Phenylalanine Dual‐Modified Dendrimer | |
| RU2856223C2 (ru) | Способ упаковки белка, рнк или комплекса белка с рнк в частицу, частица, полученная указанным способом, её применение и фармацевтическая композиция на её основе | |
| Dev et al. | Advancements of CRISPR/Cas9 technology and its value in antiviral therapeutics: CRISPR/Cas9 in antiviral therapeutics | |
| Kundu et al. | Developing New Molecular-Targeted Therapeutics,‘from Gene to Drug' | |
| Nunes | Development of cationic polymeric nanoparticles for plasmid DNA vaccine delivery | |
| WO2025172945A1 (ru) | Способ упаковки белка, рнк или комплекса белка с рнк в частицу |